Navigation Links
How amyloid beta reduces plasticity related to synaptic signaling
Date:12/28/2009

The early stages of Alzheimer's disease are thought to occur at the synapse, since synapse loss is associated with memory dysfunction. Evidence suggests that amyloid beta (Aβ) plays an important role in early synaptic failure, but little has been understood about Aβ's effect on the plasticity of dendritic spines.

These spines are short outgrowths of dendrites (extensions of neurons) that relay electrical impulses in the brain. A single neuron's dendrite contains hundreds of thousands of spines, providing memory storage and transmission of signals across the synapse the junction where such nerve impulses occur. Plasticity of these spines, or the ability to change and grow, is essential for the transmission of signaling in the brain.

Researchers led by Roberto Malinow, MD, PhD, professor of neurosciences and Shiley-Marcos Endowed Professor in Alzheimer's Disease Research at the University of California, San Diego School of Medicine, have shed more light on how Aβ's destructive effects on the brain are related to its impact on the plasticity of dentritic spines. Their study was published on December 27 in the journal Nature Neuroscience.

The researchers have shown that if Aβ is over-produced by either the pre-or post-synaptic side of the axon, it can cause destructive effects. Secondly, these effects are over a distances of about 10 microns of the neuron affecting thousands and thousands of synapses.

"We found that amyloid beta affects structural and not just functional, plasticity," said Malinow. "Normally, plasticity can be induced, which makes synapses stronger and bigger, but amyloid beta prevents this."

According to Malinow, it also appears that continuous release of Aβ is required to prevent plasticity. "Even a short window of 30 to 60 minutes without Aβ secretion is enough to permit plasticity to occur," he said. As Aβ's effect on the dendritic spines critical for memory had been thought to be irreversible, this shows that there is a hope of change if scientists learn how to stop the secretion of Aβ at synaptic sites."

"Our results show that the continuous production of Aβ at dendrites or axons acts locally to reduce the number and plasticity of synapses," Malinow concluded.


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Manipulating brain inflammation may help clear brain of amyloid plaques, Mayo Clinic researchers say
2. HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimers Disease
3. A Phase III Alzheimers Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits
4. Novel role of protein in generating amyloid-beta peptide
5. Amyloid Beta Level in Serum Predicts Risk for Vascular Disease in First-Degree Relatives of Alzheimer's Patients
6. Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
7. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
8. News brief: Knockdown of E2F1 reduces invasive potential of melanoma cells
9. Researchers find increased dairy intake reduces risk of uterine fibroids in black women
10. Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care
11. Elastography reduces unnecessary breast biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: